CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

Neurology

Volumn 59, Issue 4, 2002, Pages 627-629

  Buerger, K ^a   Teipel, S J ^a   Zinkowski, Ray ^a   Blennow, K ^a   Arai, H ^a   Engel, R ^a   Hofmann Kiefer, K ^a   McCulloch, C ^a   Ptok, U ^a   Heun, R ^a   Andreasen, N ^a   DeBernardis, J ^a   Kerkman, D ^a   Moeller, H J ^a   Davies, P ^a   Hampel, H ^a  

^a Molecular Geriatrics Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CARRIER PROTEIN; TAU PROTEIN; THREONINE;

AGING; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; LONGITUDINAL STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RISK FACTOR;

EID: 0037183481     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.4.627     Document Type: Article

References (10)

1. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals
2. Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
3. Tracking of Alzheimer's disease progression with CSF tau protein phosphorylated at threonine 231
4. Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease
5. CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease
6. Consensus Report of the Working Group on "Molecular and Biochemical Markers of Alzheimer's Disease."
7. The prevalence of dementia: A quantitative integration of the literature
8. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease
9. Cerebrospinal fluid tau and A-beta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
10. CSF phosphorylated tau protein and mild cognitive impairment: A prospective study